ALNY
Alnylam Pharmaceuticals Inc

4,359
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Oct 30,
Pre-Market

Estimated EPS

$0.37

Estimated Rev

$921.3M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
$0.37
--
--
N/A
Q2 '25
-$0.54
-$0.51
6.20%
BEAT
Q1 '25
-$0.89
-$0.44
50.56%
BEAT
Q4 '24
-$0.60
-$0.65
-9.17%
MISSED
Q3 '24
-$0.92
-$0.87
5.09%
BEAT

Latest ALNY News

View

Advertisement. Remove ads.

Advertisement. Remove ads.